Accéder au contenu
Merck
Toutes les photos(1)

Documents

F0040010

Carbendazim

European Pharmacopoeia (EP) Reference Standard

Synonyme(s) :

2-benzimidazolecarbamate de méthyle

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(1)

About This Item

Formule empirique (notation de Hill):
C9H9N3O2
Numéro CAS:
10605-21-7
Poids moléculaire :
191.19
Numéro Beilstein :
649044
Numéro MDL:
MFCD00055390
Code UNSPSC :
41116107
ID de substance PubChem :
329799622
Nomenclature NACRES :
NA.24

Qualité

pharmaceutical primary standard

Famille d'API

fenbendazole

Fabricant/nom de marque

EDQM

Pf

>300 °C (lit.)

Application(s)

pharmaceutical (small molecule)

Format

neat

Température de stockage

2-8°C

Chaîne SMILES 

COC(=O)Nc1nc2ccccc2[nH]1

InChI

1S/C9H9N3O2/c1-14-9(13)12-8-10-6-4-2-3-5-7(6)11-8/h2-5H,1H3,(H2,10,11,12,13)

Clé InChI

TWFZGCMQGLPBSX-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Fenbendazole impurity A EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Conditionnement

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Autres remarques

Sales restrictions may apply.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

1269403

Fenbendazole, United States Pharmacopeia (USP) Reference Standard

F0040000

Fenbendazole, European Pharmacopoeia (EP) Reference Standard

F0040020

Fenbendazole impurity B, European Pharmacopoeia (EP) Reference Standard

1269414

Carbendazim, United States Pharmacopeia (USP) Reference Standard

1269425

Fenbendazole Related Compound B, United States Pharmacopeia (USP) Reference Standard

PHR1832

Fenbendazole, Pharmaceutical Secondary Standard; Certified Reference Material

BP692

Fenbendazole, British Pharmacopoeia (BP) Reference Standard

PHR2863

Fenbendazole Related Compound B, certified reference material, pharmaceutical secondary standard

Pictogrammes

Health hazardExclamation markEnvironment
GHS08,GHS07,GHS09

Mention d'avertissement

Danger

Mentions de danger

H317,H340,H360FD,H410

Classification des risques

Aquatic Acute 1 - Aquatic Chronic 1 - Muta. 1B - Repr. 1B - Skin Sens. 1

Code de la classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Désolés, nous n'avons pas de COA pour ce produit disponible en ligne pour le moment.

Si vous avez besoin d'assistance, veuillez contacter Service Clients

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Les clients ont également consulté

Slide 1 of 1

1 of 1

Carbendazim PESTANAL®, analytical standard

Supelco

45368

Carbendazim

Christoph Thalhammer et al.
Nephrology (Carlton, Vic.), 20(2), 91-95 (2014-10-28)
Haemodynamic stability of patients during haemodialysis (HD) sessions is of pivotal importance and accurate determination of dry weight remains a challenge. Little information is available about central venous and aortic pressure during dialysis. In this pilot study we used a
Jae-Ran Lee et al.
Human mutation, 36(1), 69-78 (2014-09-30)
KIF1A is a neuron-specific motor protein that plays important roles in cargo transport along neurites. Recessive mutations in KIF1A were previously described in families with spastic paraparesis or sensory and autonomic neuropathy type-2. Here, we report 11 heterozygous de novo
D K Bayer et al.
Clinical and experimental immunology, 178(3), 459-469 (2014-07-22)
In areas without newborn screening for severe combined immunodeficiency (SCID), disease-defining infections may lead to diagnosis, and in some cases, may not be identified prior to the first year of life. We describe a female infant who presented with disseminated
Wojciech Dabrowski et al.
Clinical nephrology, 82(1), 41-50 (2014-06-03)
To analyze the effect and the time course of continuous veno-venous hemofiltration (CVVH) with net ultrafiltration (UF) on intra-abdominal pressure (IAP) body fluid volumes in septic shock patients with acute kidney injury (AKI). Patients were studied at baseline and after
Petra Hegerová et al.
Nutrition (Burbank, Los Angeles County, Calif.), 31(1), 166-170 (2014-12-04)
An acute disease is regularly associated with inflammation, decreased food intake, and low physical activity; the consequence is loss of muscle mass. However, the restoration of muscle tissue is problematic, especially in older patients. Loss of muscle mass leads to
Afficher tous les articles scientifiques apparentés

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique